U.S. Rep. Mariannette Miller-Meeks wants to reverse a phased ban on TCE, a cancer-causing chemical found in consumer products ...
A toxic, cancer-causing chemical was banned by the EPA. Now, some in Congress want to reverse course
In December, the EPA announced a phased ban of a cancer-causing chemical that can persist in groundwater. Iowa’s 1st District ...
The EPA’s delayed action on chemicals goes beyond those that fall under the jurisdiction of TSCA. The agency has also sought to delay cases challenging regulations under the Clean Air Act. One of the ...
Oxford BioTherapeutics (OBT) has lined up another big pharma partner for its drug discovery platform, agreeing to work with Roche on the hunt for new antibody therapeutics for cancer in a deal worth ...
Key Biden-era toxics rules were left out of what Administrator Lee Zeldin touted as the "biggest deregulatory action in U.S. history." ...
A health department analysis found the number of birth defects in Southeast Como fell in normal ranges compared to the rest of the state, Messing said, and the department is doing a similar analysis ...
A toxic, cancer-causing chemical was banned by the EPA. Now, some in Congress want to reverse course
Federal and international agencies say there’s strong evidence TCE exposure can cause kidney cancer, and it’s linked to liver cancer, non-Hodgkin’s lymphoma, Parkinson’s disease, birth defects and ...
Normunity's lead development programme NRM-823 is a novel T-cell engager (TCE) against an undisclosed, cancer cell-specific target that the company says is relevant to multiple solid tumours.
What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback